ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,357Medicare Part D Prescriptions Filled, Including Refills

Rank: 309 out of 1383

$573K Total Retail Price of All Prescriptions

Rank: 277 out of 1383

510 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 510 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

13% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 8,061 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
OMEPRAZOLE 381 262 1 5
LEVOTHYROXINE SODIUM 375 346 2 4
SIMVASTATIN 301 241 3 2
FUROSEMIDE 276 212 4 7
WARFARIN SODIUM 260 243 5 13
INDAPAMIDE 243 222 6 153
METFORMIN HCL 231 181 7 8
LISINOPRIL 231 193 7 3
HYDROCODONE-ACETAMINOPHEN 225 144 S3 9 1
AMLODIPINE BESYLATE 198 167 10 6
LOSARTAN POTASSIUM 183 170 11 23
CITALOPRAM HBR 165 128 12 15
GABAPENTIN 162 79 13 11
CARVEDILOL 148 97 14 24
POTASSIUM CHLORIDE 137 105 15 12
PANTOPRAZOLE SODIUM 116 95 16 32
SPIRONOLACTONE 108 78 17 67
ALLOPURINOL 107 98 18 33
METOPROLOL SUCCINATE 105 105 19 29
METOPROLOL TARTRATE 103 75 20 9
DIGOXIN 103 89 20 59
ISOSORBIDE MONONITRATE ER 98 73 22 66
CLOPIDOGREL 97 83 23 28
NAMENDA 96 96 24 49
FLUTICASONE PROPIONATE 92 78 25 39
TAMSULOSIN HCL 89 79 26 30
ZOLPIDEM TARTRATE 88 72 27 17
VYTORIN 88 79 27 184
METOCLOPRAMIDE HCL 82 51 29 127
DOXYCYCLINE HYCLATE 82 50 29 94
CRESTOR 81 42 31 34
MELOXICAM 81 58 31 20
SERTRALINE HCL 80 70 33 21
ENALAPRIL MALEATE 78 60 34 75
RANITIDINE HCL 77 72 35 19
NEXIUM 74 61 36 26
GLIMEPIRIDE 73 67 37 31
ZETIA 72 66 38 101
TRAZODONE HCL 69 31 39 36
PLAVIX 68 62 40 43
ATORVASTATIN CALCIUM 66 60 41 18
PREDNISONE 65 51 42 40
ESTRADIOL 65 26 R 42 96
ESCITALOPRAM OXALATE 64 61 44 99
FENOFIBRATE 62 31 45 65
JANUVIA 61 61 46 85
KLOR-CON 10 58 52 47 74
QUETIAPINE FUMARATE 58 35 47 70
IPRATROPIUM BROMIDE 57 57 49 174
DIOVAN 54 52 50 58
BUPROPION HCL SR 53 0 51 194
PRAVASTATIN SODIUM 51 40 52 14
TRAMADOL HCL 51 32 52 25
HYDROCHLOROTHIAZIDE 50 45 54 10
ALENDRONATE SODIUM 50 45 54 37
CEPHALEXIN 50 44 54 87
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.